300962 Stock Overview
Zhongjin Irradiation Incorporated Company provides irradiation technology services in China.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Zhongjin Irradiation Incorporated Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.09 |
52 Week High | CN¥19.24 |
52 Week Low | CN¥10.18 |
Beta | 0.46 |
1 Month Change | 6.64% |
3 Month Change | -2.20% |
1 Year Change | -6.74% |
3 Year Change | -43.10% |
5 Year Change | n/a |
Change since IPO | -56.51% |
Recent News & Updates
Recent updates
Shareholder Returns
300962 | CN Healthcare | CN Market | |
---|---|---|---|
7D | -7.1% | 0.2% | -0.3% |
1Y | -6.7% | -35.2% | -14.6% |
Return vs Industry: 300962 exceeded the CN Healthcare industry which returned -35.2% over the past year.
Return vs Market: 300962 exceeded the CN Market which returned -14.6% over the past year.
Price Volatility
300962 volatility | |
---|---|
300962 Average Weekly Movement | 10.2% |
Healthcare Industry Average Movement | 6.7% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300962's share price has been volatile over the past 3 months.
Volatility Over Time: 300962's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 582 | Dongbo Zhang | www.zjfzgroup.com |
Zhongjin Irradiation Incorporated Company provides irradiation technology services in China. It offers irradiation sterilization services for medical and health care products, food, medicines, packaging materials, and other products; and irradiation modification services for polymer materials. The company was incorporated in 2003 and is based in Shenzhen, China.
Zhongjin Irradiation Incorporated Company Fundamentals Summary
300962 fundamental statistics | |
---|---|
Market cap | CN¥3.91b |
Earnings (TTM) | CN¥108.61m |
Revenue (TTM) | CN¥348.04m |
36.7x
P/E Ratio11.4x
P/S RatioIs 300962 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300962 income statement (TTM) | |
---|---|
Revenue | CN¥348.04m |
Cost of Revenue | CN¥0 |
Gross Profit | CN¥348.04m |
Other Expenses | CN¥239.43m |
Earnings | CN¥108.61m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Apr 27, 2024
Earnings per share (EPS) | 0.41 |
Gross Margin | 100.00% |
Net Profit Margin | 31.21% |
Debt/Equity Ratio | 1.3% |
How did 300962 perform over the long term?
See historical performance and comparison